Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Kyle Rove

Concepts (306)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urologic Surgical Procedures
15
2026
126
6.580
Why?
Prostatic Neoplasms
17
2014
972
2.800
Why?
Urinary Bladder
6
2026
194
2.730
Why?
Urinary Bladder, Neurogenic
4
2026
46
2.320
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2026
344
2.020
Why?
Androgen Antagonists
5
2014
91
1.780
Why?
Analgesics, Opioid
10
2026
1221
1.750
Why?
Abdominal Neoplasms
2
2025
48
1.720
Why?
Urology
5
2024
63
1.620
Why?
Perioperative Care
3
2024
235
1.590
Why?
Postoperative Complications
11
2026
3034
1.520
Why?
Urodynamics
5
2025
44
1.480
Why?
Length of Stay
10
2026
1358
1.350
Why?
Child
40
2026
22693
1.160
Why?
Renal Insufficiency, Chronic
2
2026
640
1.140
Why?
Acute Kidney Injury
2
2026
866
1.020
Why?
Spinal Dysraphism
4
2025
113
1.010
Why?
Testosterone
5
2015
419
0.980
Why?
Ketorolac
1
2026
33
0.950
Why?
Ibuprofen
1
2026
87
0.930
Why?
Child, Preschool
19
2026
11913
0.900
Why?
Negative-Pressure Wound Therapy
1
2025
29
0.860
Why?
Urinary Bladder Neoplasms
3
2017
259
0.850
Why?
Ileum
1
2025
112
0.850
Why?
Testicular Neoplasms
2
2016
108
0.850
Why?
Pediatrics
4
2026
1124
0.830
Why?
Metabolic Diseases
1
2025
114
0.820
Why?
Prospective Studies
16
2026
8123
0.810
Why?
Kidney Calculi
4
2025
43
0.800
Why?
Neuroblastoma
1
2025
177
0.800
Why?
Specialties, Surgical
1
2025
88
0.790
Why?
Practice Patterns, Physicians'
3
2024
1408
0.790
Why?
Neoplasms, Hormone-Dependent
2
2014
33
0.790
Why?
Physicians, Women
1
2025
92
0.780
Why?
Robotic Surgical Procedures
1
2026
210
0.760
Why?
Urinary Bladder Diseases
1
2022
18
0.740
Why?
Surgeons
2
2025
351
0.740
Why?
Drug Prescriptions
1
2024
314
0.720
Why?
Ureter
1
2022
37
0.720
Why?
Delphi Technique
1
2024
350
0.710
Why?
Propensity Score
1
2024
376
0.710
Why?
Lower Urinary Tract Symptoms
2
2025
62
0.710
Why?
Male
47
2026
73396
0.700
Why?
Humans
71
2026
146342
0.700
Why?
Gonadotropin-Releasing Hormone
3
2014
215
0.700
Why?
Surgical Wound Infection
1
2025
349
0.670
Why?
Postoperative Nausea and Vomiting
1
2020
23
0.650
Why?
Urologic Diseases
2
2018
44
0.650
Why?
Analgesia
1
2020
106
0.600
Why?
Adolescent
21
2026
22557
0.580
Why?
Hyperoxaluria, Primary
3
2023
14
0.570
Why?
Wolfram Syndrome
1
2018
5
0.550
Why?
Pons
1
2018
33
0.540
Why?
Urination
1
2018
46
0.530
Why?
Bone Neoplasms
2
2011
272
0.530
Why?
Prostate-Specific Antigen
4
2014
162
0.520
Why?
Electronic Health Records
2
2025
1210
0.500
Why?
Ureteroscopy
3
2025
16
0.500
Why?
Recovery of Function
2
2018
725
0.490
Why?
Sertoli-Leydig Cell Tumor
1
2016
8
0.490
Why?
Cystoscopy
1
2016
21
0.480
Why?
Evidence-Based Medicine
2
2018
731
0.480
Why?
Bariatric Surgery
1
2020
250
0.470
Why?
Sex Cord-Gonadal Stromal Tumors
1
2015
5
0.460
Why?
Cause of Death
2
2023
456
0.450
Why?
Female
25
2026
79499
0.430
Why?
Retrospective Studies
16
2025
17438
0.410
Why?
Ureteral Calculi
2
2025
15
0.410
Why?
Prostate
2
2012
159
0.410
Why?
Lithotripsy
2
2025
47
0.400
Why?
Multicenter Studies as Topic
3
2026
417
0.400
Why?
Orchiectomy
4
2025
72
0.380
Why?
Patient Care Team
2
2018
701
0.370
Why?
Young Adult
10
2026
14330
0.360
Why?
Radiotherapy
3
2025
209
0.360
Why?
Pediatric Obesity
1
2020
635
0.360
Why?
Incidence
4
2024
2936
0.360
Why?
Tonsillectomy
2
2024
106
0.350
Why?
Prognosis
5
2025
4351
0.350
Why?
Antineoplastic Agents, Hormonal
1
2013
196
0.340
Why?
Treatment Outcome
10
2025
11821
0.340
Why?
Azasteroids
1
2011
5
0.330
Why?
5-alpha Reductase Inhibitors
1
2011
16
0.330
Why?
Infant
6
2026
10114
0.330
Why?
Referral and Consultation
1
2017
881
0.320
Why?
Anticarcinogenic Agents
1
2011
63
0.320
Why?
Disease Progression
4
2015
2867
0.310
Why?
Kidney Neoplasms
3
2019
419
0.310
Why?
Sleep Apnea, Obstructive
2
2024
300
0.300
Why?
Registries
1
2018
2400
0.280
Why?
Risk Assessment
4
2024
3712
0.280
Why?
Follow-Up Studies
5
2025
5439
0.280
Why?
Wilms Tumor
2
2019
91
0.270
Why?
Neoplasm Staging
4
2016
1488
0.270
Why?
Early Detection of Cancer
2
2011
506
0.250
Why?
Adenoidectomy
2
2024
82
0.240
Why?
Urinary Catheterization
1
2026
35
0.230
Why?
Sex Factors
2
2025
2107
0.230
Why?
Pelvic Neoplasms
1
2025
24
0.230
Why?
Antineoplastic Agents
3
2012
2219
0.230
Why?
Nephrolithotomy, Percutaneous
1
2025
5
0.220
Why?
Spermatic Cord Torsion
1
2025
7
0.220
Why?
Urinary Tract
1
2025
47
0.220
Why?
Case-Control Studies
3
2023
3647
0.210
Why?
Fecal Incontinence
1
2025
90
0.210
Why?
Fractures, Bone
1
2009
436
0.200
Why?
Randomized Controlled Trials as Topic
2
2026
1763
0.200
Why?
Nephrocalcinosis
1
2023
12
0.200
Why?
Nephrolithiasis
1
2023
10
0.200
Why?
Neoplasm Metastasis
2
2016
693
0.190
Why?
Risk Factors
4
2025
10921
0.180
Why?
Analgesia, Epidural
1
2022
38
0.180
Why?
Meningomyelocele
1
2023
63
0.180
Why?
Pilot Projects
2
2025
1888
0.180
Why?
Survival Analysis
2
2016
1378
0.170
Why?
Hydrocephalus
1
2023
115
0.170
Why?
Double-Blind Method
1
2026
2070
0.170
Why?
Spinal Cord Injuries
1
2025
238
0.170
Why?
Stents
2
2023
554
0.170
Why?
Device Removal
1
2022
149
0.160
Why?
Cohort Studies
2
2024
6077
0.160
Why?
RANK Ligand
2
2010
29
0.160
Why?
Diphosphonates
2
2011
68
0.160
Why?
Anastomosis, Surgical
1
2020
164
0.150
Why?
Surveys and Questionnaires
5
2025
6073
0.150
Why?
Combined Modality Therapy
2
2014
1271
0.150
Why?
Age Factors
2
2018
3347
0.150
Why?
Sex-Determining Region Y Protein
1
2019
7
0.150
Why?
WT1 Proteins
1
2019
12
0.150
Why?
Emotions
1
2024
559
0.140
Why?
Nephrotic Syndrome
1
2019
44
0.140
Why?
Disorders of Sex Development
1
2019
40
0.140
Why?
Urethral Neoplasms
1
2018
3
0.140
Why?
Hypertension, Renal
1
2018
15
0.140
Why?
Urethral Obstruction
1
2018
7
0.140
Why?
Paraganglioma, Extra-Adrenal
1
2018
10
0.140
Why?
Polyps
1
2018
13
0.140
Why?
Renal Artery Obstruction
1
2018
30
0.140
Why?
Caregivers
2
2024
1080
0.130
Why?
Urethra
1
2018
55
0.130
Why?
Prenatal Diagnosis
1
2019
190
0.130
Why?
Magnetic Resonance Imaging
3
2019
3926
0.130
Why?
Intestines
1
2020
351
0.130
Why?
Kidney Failure, Chronic
1
2023
589
0.130
Why?
Practice Guidelines as Topic
2
2018
1591
0.130
Why?
Men's Health
1
2017
6
0.130
Why?
Organ Size
1
2018
465
0.130
Why?
Review Literature as Topic
1
2017
53
0.120
Why?
Decision Making
1
2024
993
0.120
Why?
Postoperative Period
1
2018
355
0.120
Why?
Pain Management
1
2020
421
0.120
Why?
Adult
8
2024
41087
0.120
Why?
Tertiary Care Centers
1
2017
196
0.120
Why?
Immunotherapy
2
2011
671
0.120
Why?
Quality Improvement
1
2025
1354
0.120
Why?
Feminization
1
2015
6
0.120
Why?
Mitotic Index
1
2015
24
0.120
Why?
Databases, Factual
2
2022
1493
0.110
Why?
Intermittent Urethral Catheterization
1
2015
4
0.110
Why?
Urination Disorders
1
2015
15
0.110
Why?
Clinical Trials as Topic
1
2020
1064
0.110
Why?
Ultrasonography
3
2019
788
0.110
Why?
Cloaca
1
2015
52
0.110
Why?
Neoplasm Invasiveness
1
2016
504
0.110
Why?
Disease-Free Survival
1
2016
778
0.100
Why?
Colorectal Neoplasms
1
2022
874
0.100
Why?
Kaplan-Meier Estimate
1
2016
970
0.100
Why?
Antibodies, Monoclonal
2
2011
1512
0.100
Why?
Patient Reported Outcome Measures
1
2018
516
0.100
Why?
Image Processing, Computer-Assisted
1
2018
778
0.100
Why?
Self Report
1
2018
870
0.100
Why?
Creatinine
1
2015
511
0.100
Why?
Infant, Newborn
4
2019
6460
0.090
Why?
Estrogens
1
2015
364
0.090
Why?
Radiation-Protective Agents
1
2012
16
0.090
Why?
Multivariate Analysis
1
2016
1543
0.090
Why?
Metalloporphyrins
1
2012
62
0.090
Why?
Alpha Particles
1
2011
1
0.090
Why?
Beta Particles
1
2011
1
0.090
Why?
Drug Design
1
2013
180
0.090
Why?
Quality of Life
2
2018
3200
0.090
Why?
Telemedicine
1
2021
966
0.090
Why?
Endothelin A Receptor Antagonists
1
2011
24
0.090
Why?
Clusterin
1
2011
11
0.090
Why?
Receptors, Androgen
1
2013
149
0.090
Why?
Obesity
1
2025
3131
0.090
Why?
Mitomycin
1
2011
31
0.090
Why?
Blood Chemical Analysis
1
2012
109
0.090
Why?
Valproic Acid
1
2011
45
0.090
Why?
Drug Costs
1
2012
116
0.080
Why?
Kidney
2
2019
1498
0.080
Why?
Dutasteride
1
2011
5
0.080
Why?
Carcinoma, Transitional Cell
1
2011
70
0.080
Why?
United States
4
2025
16136
0.080
Why?
Logistic Models
1
2016
2126
0.080
Why?
Androstenols
1
2010
4
0.080
Why?
Tissue Extracts
1
2010
19
0.080
Why?
Denosumab
1
2010
10
0.080
Why?
Bone Density Conservation Agents
1
2011
83
0.080
Why?
Prostatic Hyperplasia
1
2011
40
0.080
Why?
Androstenes
1
2010
16
0.080
Why?
Dihydrotestosterone
1
2011
40
0.080
Why?
Patient Care Management
1
2011
54
0.080
Why?
Antigens, Neoplasm
1
2012
271
0.080
Why?
Phenylthiohydantoin
1
2010
44
0.080
Why?
Imaging, Three-Dimensional
2
2012
582
0.080
Why?
Guideline Adherence
1
2015
594
0.080
Why?
Antibiotics, Antineoplastic
1
2011
141
0.080
Why?
Taxoids
1
2010
115
0.080
Why?
Longitudinal Studies
1
2018
3017
0.080
Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2010
2
0.080
Why?
Biomedical Research
1
2017
729
0.080
Why?
Histone Deacetylase Inhibitors
1
2011
219
0.080
Why?
Hormone Antagonists
1
2009
32
0.080
Why?
Benzamides
1
2010
226
0.070
Why?
Cost-Benefit Analysis
1
2012
640
0.070
Why?
Nitriles
1
2010
212
0.070
Why?
Bone Remodeling
1
2009
71
0.070
Why?
Mobility Limitation
1
2009
68
0.070
Why?
Risk
1
2011
920
0.070
Why?
Collagen Type I
1
2009
144
0.070
Why?
Antioxidants
1
2012
544
0.070
Why?
Continuity of Patient Care
1
2011
298
0.070
Why?
Mutation
1
2019
4093
0.070
Why?
Middle Aged
6
2016
36619
0.060
Why?
Aged
4
2016
26432
0.060
Why?
Drug Resistance, Neoplasm
1
2013
893
0.060
Why?
Biomarkers, Tumor
1
2014
1339
0.060
Why?
Computer Simulation
1
2011
1014
0.060
Why?
Software
1
2011
676
0.060
Why?
Protein Kinase Inhibitors
1
2011
983
0.050
Why?
Clinical Protocols
1
2026
282
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2010
992
0.050
Why?
Calcium Oxalate
1
2023
7
0.050
Why?
Canada
1
2025
432
0.050
Why?
Peptides
1
2009
992
0.050
Why?
Ambulatory Surgical Procedures
1
2024
82
0.050
Why?
Mass Screening
1
2011
1307
0.050
Why?
Polysomnography
1
2024
239
0.050
Why?
Ventriculoperitoneal Shunt
1
2023
44
0.050
Why?
Predictive Value of Tests
2
2022
2113
0.050
Why?
Colostomy
1
2022
28
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
1998
0.040
Why?
Morphine
1
2022
171
0.040
Why?
Animals
3
2013
38107
0.040
Why?
Urologists
1
2021
20
0.040
Why?
Internship and Residency
1
2011
1281
0.040
Why?
Signal Transduction
1
2013
5246
0.040
Why?
Feasibility Studies
1
2023
1135
0.040
Why?
Cytoskeletal Proteins
1
2019
146
0.040
Why?
Consensus
1
2021
467
0.040
Why?
Metanephrine
1
2018
4
0.030
Why?
Normetanephrine
1
2018
4
0.030
Why?
Cystography
1
2018
3
0.030
Why?
Renin
1
2018
33
0.030
Why?
Patient Readmission
1
2024
778
0.030
Why?
Urinary Retention
1
2018
23
0.030
Why?
Lymph Node Excision
1
2019
174
0.030
Why?
Oxygen
1
2023
997
0.030
Why?
Nephrectomy
1
2019
172
0.030
Why?
Chemotherapy, Adjuvant
1
2019
429
0.030
Why?
DNA Mutational Analysis
1
2019
410
0.030
Why?
Norepinephrine
1
2018
201
0.030
Why?
Abnormalities, Multiple
1
2019
195
0.030
Why?
Epithelium
1
2018
295
0.030
Why?
Patient Satisfaction
1
2021
706
0.030
Why?
Global Burden of Disease
1
2017
25
0.030
Why?
Urologic Neoplasms
1
2017
31
0.030
Why?
Computed Tomography Angiography
1
2018
151
0.030
Why?
Quality-Adjusted Life Years
1
2017
122
0.030
Why?
Infertility, Male
1
2017
69
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2019
429
0.030
Why?
Statistics, Nonparametric
1
2017
426
0.030
Why?
Genetic Testing
1
2019
492
0.030
Why?
Endoscopy
1
2018
316
0.030
Why?
Urinary Diversion
1
2015
15
0.030
Why?
Kidney Function Tests
1
2015
156
0.030
Why?
Diagnosis, Differential
1
2019
1503
0.030
Why?
Pandemics
1
2021
1707
0.020
Why?
Image-Guided Biopsy
1
2012
41
0.020
Why?
Penis
1
2012
33
0.020
Why?
Erectile Dysfunction
1
2012
35
0.020
Why?
Prostatectomy
1
2012
93
0.020
Why?
Radiation, Ionizing
1
2012
84
0.020
Why?
Testis
1
2012
158
0.020
Why?
Neoplasm Grading
1
2012
313
0.020
Why?
Glomerular Filtration Rate
1
2015
745
0.020
Why?
Drug Synergism
1
2011
354
0.020
Why?
Biopsy, Needle
1
2011
183
0.020
Why?
Cross-Sectional Studies
1
2022
5899
0.020
Why?
Efficiency
1
2011
102
0.020
Why?
Emergency Service, Hospital
1
2023
2363
0.020
Why?
Tumor Cells, Cultured
1
2011
882
0.020
Why?
Reference Values
1
2011
796
0.020
Why?
DNA Damage
1
2012
439
0.020
Why?
Workload
1
2011
170
0.020
Why?
Safety
1
2011
347
0.020
Why?
Drug Therapy, Combination
1
2011
1036
0.020
Why?
Tomography, X-Ray Computed
1
2019
2786
0.020
Why?
Skin
1
2012
701
0.020
Why?
Rats, Sprague-Dawley
1
2012
2537
0.020
Why?
Pregnancy
1
2019
7230
0.010
Why?
Time Factors
1
2017
7109
0.010
Why?
Models, Biological
1
2012
1761
0.010
Why?
Rats
1
2012
5586
0.010
Why?
Reproducibility of Results
1
2011
3416
0.010
Why?
Rove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)